147 related articles for article (PubMed ID: 23121700)
21. Effect of intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in neovascular glaucoma.
Sevim MS; Buttanri IB; Kugu S; Serin D; Sevim S
Ophthalmologica; 2013; 229(2):94-100. PubMed ID: 23364308
[TBL] [Abstract][Full Text] [Related]
22. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma.
Chalam KV; Gupta SK; Grover S; Brar VS; Agarwal S
Eur J Ophthalmol; 2008; 18(2):255-62. PubMed ID: 18320519
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma.
Ha JY; Lee TH; Sung MS; Park SW
Korean J Ophthalmol; 2017 Dec; 31(6):538-547. PubMed ID: 29022296
[TBL] [Abstract][Full Text] [Related]
24. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma.
Wasik A; Song HF; Grimes A; Engelke C; Thomas A
Optometry; 2009 May; 80(5):243-8. PubMed ID: 19410229
[TBL] [Abstract][Full Text] [Related]
25. Role of intravitreal bevacizumab in neovascular glaucoma.
Gheith ME; Siam GA; de Barros DS; Garg SJ; Moster MR
J Ocul Pharmacol Ther; 2007 Oct; 23(5):487-91. PubMed ID: 17900231
[TBL] [Abstract][Full Text] [Related]
26. Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma.
Lim TH; Bae SH; Cho YJ; Lee JH; Kim HK; Sohn YH
Korean J Ophthalmol; 2009 Sep; 23(3):188-92. PubMed ID: 19794946
[TBL] [Abstract][Full Text] [Related]
27. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
[TBL] [Abstract][Full Text] [Related]
28. The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma.
Gupta V; Jha R; Rao A; Kong G; Sihota R
Eur J Ophthalmol; 2009; 19(3):435-41. PubMed ID: 19396791
[TBL] [Abstract][Full Text] [Related]
29. Case-matched comparison of vitrectomy, peripheral retinal endolaser, and endocyclophotocoagulation versus standard care in neovascular glaucoma.
Marra KV; Wagley S; Omar A; Kinoshita T; Kovacs KD; Silva P; Kuperwaser MC; Arroyo JG
Retina; 2015 Jun; 35(6):1072-83. PubMed ID: 25621944
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma.
Miki A; Oshima Y; Otori Y; Kamei M; Tano Y
Br J Ophthalmol; 2008 Oct; 92(10):1431-3. PubMed ID: 18815428
[No Abstract] [Full Text] [Related]
31. Intravitreal bevacizumab for filtering surgery.
Jonas JB; Spandau UH; Schlichtenbrede F
Ophthalmic Res; 2007; 39(2):121-2. PubMed ID: 17284939
[TBL] [Abstract][Full Text] [Related]
32. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
[TBL] [Abstract][Full Text] [Related]
33. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term.
Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M
BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739
[TBL] [Abstract][Full Text] [Related]
34. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
Yazdani S; Hendi K; Pakravan M
J Glaucoma; 2007 Aug; 16(5):437-9. PubMed ID: 17700285
[TBL] [Abstract][Full Text] [Related]
35. [The treatment of the rubeosis of the iris and the neovascular glaucoma in proliferative diabetic retinopathy by means of anti-VEGF].
Cernák M; Markovic O; Cernák A
Cesk Slov Oftalmol; 2008 Nov; 64(6):234-6. PubMed ID: 19110964
[TBL] [Abstract][Full Text] [Related]
36. Topical bevacizumab for neovascular glaucoma: a pilot study.
Waisbourd M; Shemesh G; Kurtz S; Rachmiel R; Moisseiev E; Zayit-Soudri S; Loewenstein A; Barequet I
Pharmacology; 2014; 93(3-4):108-12. PubMed ID: 24556733
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
dell'Omo R; Kulkarni A; Franks WA
Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
[No Abstract] [Full Text] [Related]
38. Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy.
Yeh PT; Yang CM; Lin YC; Chen MS; Yang CH
Retina; 2009 Jun; 29(6):768-74. PubMed ID: 19516117
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal bevacizumab in a patient with neovascular glaucoma.
Kahook MY; Schuman JS; Noecker RJ
Ophthalmic Surg Lasers Imaging; 2006; 37(2):144-6. PubMed ID: 16583637
[TBL] [Abstract][Full Text] [Related]
40. Bevacizumab (Avastin) for the treatment of neovascular glaucoma.
Chilov MN; Grigg JR; Playfair TJ
Clin Exp Ophthalmol; 2007 Jul; 35(5):494-6. PubMed ID: 17651259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
